Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
Actual shortage: | 53 (11%) | |
Anticipated shortage: | 21 (5%) | |
Avoided shortage: | 9 (2%) | |
Resolved: | 382 (82%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (15%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TRAMADOL/ACET | 37.5MG 325.0MG | TABLET | Resolved | 2020-01-17 | 2020-06-06 | 103483 |
LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67312 |
LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2021-09-13 | 2024-05-29 | 145547 |
LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67321 |
LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145537 |
LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Anticipated shortage | 2024-05-28 | 2024-05-28 | 229003 |
LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67315 |
LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82941 |
LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-05-29 | 145541 |
ESCITALOPRAM | 10MG | TABLET | Resolved | 2021-06-09 | 2021-07-18 | 140601 |
ESCITALOPRAM | 10MG | TABLET | Actual shortage | 2024-05-28 | 2024-05-29 | 228992 |
ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-06-09 | 2021-07-15 | 140604 |
ESCITALOPRAM | 20MG | TABLET | Actual shortage | 2024-03-19 | 2024-05-28 | 222742 |
GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
CANDESARTAN | 32MG | TABLET | Resolved | 2018-09-04 | 2018-11-22 | 59777 |
CANDESARTAN | 32MG | TABLET | Resolved | 2019-01-25 | 2019-04-24 | 73520 |
CANDESARTAN | 32MG | TABLET | Resolved | 2019-10-21 | 2020-02-13 | 96884 |
CANDESARTAN | 32MG | TABLET | Resolved | 2020-03-26 | 2020-04-01 | 109439 |
CANDESARTAN | 32MG | TABLET | Resolved | 2023-10-23 | 2024-03-11 | 207878 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |